MANNATECH INC Finance Lease, Liability, Payments, Due in Rolling after Year Five
MANNATECH INC (MTEX) had Finance Lease, Liability, Payments, Due in Rolling after Year Five of $90.00 thousand as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Notes › Leases › Finance Lease, Liability, to be Paid, Rolling Maturity
us-gaap:FinanceLeaseLiabilityPaymentsDueInRollingAfterYearFive · last filed 2024-11-12
- 2024-09-30: Finance Lease, Liability, Payments, Due in Rolling after Year Five $90.00K.
- 2024-06-30: Finance Lease, Liability, Payments, Due in Rolling after Year Five $90.00K.
- 2024-03-31: Finance Lease, Liability, Payments, Due in Rolling after Year Five $90.00K.
- 2023-09-30: Finance Lease, Liability, Payments, Due in Rolling after Year Five $405.00K.
| Period end | Finance Lease, Liability, Payments, Due in Rolling after Year Five |
|---|---|
| 2024-09-30 | $90.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $90.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $90.00K 10-Q · filed 2024-05-14 |
| 2023-09-30 | $405.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $441.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $70.00K 10-Q · filed 2023-05-12 |
| 2022-09-30 | $9.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $1.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $1.00K 10-Q · filed 2022-05-13 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-12 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-12 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |